Echo Therapeutics, Inc. (ECTE) said Thursday that it has priced an underwritten public offering of 4.025 million shares of its common stock, offered at a price to the public of $2.70 per share.
The gross proceeds to Echo from this offering are expected to be about $10.9 million before deducting the underwriting discount and other estimated offering expenses payable by Echo.
Echo Therapeutics has granted the underwriters a 45-day option to purchase up to an aggregate of 603,750 additional shares of its common stock to cover over-allotments, if any.
The offering is expected to close on or about June 19, 2013, subject to customary closing conditions.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.